Literature DB >> 12465082

Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.

Jong-Hoon Kim1, Hee Yeon Jung, Ung Gu Kang, Seong Hoon Jeong, Yong Min Ahn, Hee-Jung Byun, Kyoo-Seob Ha, Yong Sik Kim.   

Abstract

The metric properties of the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) were examined in 182 subjects treated with antipsychotics. Inter-rater reliability, test-retest reliability, and concurrent validity with other rating scales for EPS were high. Four factors were identified and the optimal diagnostic cut-off scores were obtained. These results suggest that the DIEPSS is a reliable and valid multidimensional rating scale. Copyright 2002 Movement Disorder Society

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12465082     DOI： 10.1002/mds.10255

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  12 in total

1.  Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features.

Authors:  Nela Pivac; Dragica Kozarić-Kovacić
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

2.  Drug-induced parkinsonism.

Authors:  Frandy Susatia; Hubert H Fernandez
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

3.  A Neural Signature of Parkinsonism in Patients With Schizophrenia Spectrum Disorders: A Multimodal MRI Study Using Parallel ICA.

Authors:  Robert C Wolf; Mahmoud Rashidi; Stefan Fritze; Katharina M Kubera; Georg Northoff; Fabio Sambataro; Vince D Calhoun; Lena S Geiger; Heike Tost; Dusan Hirjak
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 4.  Antipsychotic combinations for schizophrenia.

Authors:  Javier Ortiz-Orendain; Santiago Castiello-de Obeso; Luis Enrique Colunga-Lozano; Yue Hu; Nicola Maayan; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2017-06-28

5.  Prolactin Levels After Switching to Paliperidone Palmitate in Patients with Schizophrenia.

Authors:  Masaru Nakamura; Takahiko Nagamine; Goro Sato; Kazue Besho
Journal:  Innov Clin Neurosci       Date:  2016-06-01

6.  Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest Reliability.

Authors:  Ami Peljto; Ljubica Zamurovic; Milica Pejovic Milovancevic; Branko Aleksic; Dusica Lecic Tosevski; Toshiya Inada
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

7.  Factors inducing falling in schizophrenia patients.

Authors:  Yoko Tsuji; Yoshiteru Akezaki; Kohei Mori; Yoshimi Yuri; Hitomi Katsumura; Tomihiro Hara; Yuki Usui; Yoritaka Fujino; Takuo Nomura; Fumio Hirao
Journal:  J Phys Ther Sci       Date:  2017-03-22

8.  Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study.

Authors:  Joseph R Calabrese; Na Jin; Brian Johnson; Pedro Such; Ross A Baker; Jessica Madera; Peter Hertel; Jocelyn Ottinger; Joan Amatniek; Hiroaki Kawasaki
Journal:  Int J Bipolar Disord       Date:  2018-06-10

9.  Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.

Authors:  Hideaki Katagiri; Mauricio Tohen; David P McDonnell; Shinji Fujikoshi; Michael Case; Shigenobu Kanba; Michihiro Takahashi; Juan-Carlos Gomez
Journal:  BMC Psychiatry       Date:  2013-05-14       Impact factor: 3.630

10.  Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia.

Authors:  Yeon-Jeong Shin; Yo-Han Joo; Jong-Hoon Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-16       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.